Prevalence of Claudin 18.2 Expression in Patient Subgroups and Co-expression of Claudin 18.2 with the KRAS G12D Mutation in Patients With Locally Advanced Unresectable or Metastatic Pancreatic Ductal Adenocarcinoma in Germany.

11. Dezember 2025

Peter J. Wild, Marco Gross-Langenhoff, Clare McCabe, Julia Bein, Anna Hof, Martin Glasstetter, Georgia Gourgioti, Lawrence Chang, Anouk van Oosten, Holly Dasghaib, Martina Jänicke, Karin Potthoff

Oncol Res Treat 2025;48 (suppl 2):195